Guérin S L, Leclerc S, Verreault H, Labrie F, Luu-The V
Laboratory of Molecular Endocrinology, Laval University Hospital Research Center, Ste-Foy, Québec, Canada.
Mol Endocrinol. 1995 Nov;9(11):1583-97. doi: 10.1210/mend.9.11.8584035.
High levels of expression for the gene encoding human type I 3 beta-hydroxysteroid dehydrogenase (3 beta-HSDI) have been detected in placenta and skin but not in adrenals, which, however, express high levels of type II 3 beta-HSD. In this study, we addressed the issue of whether the differential pattern of cell-specific expression for type I 3 beta-HSD can be explained by the differential utilization of cis-acting regulatory elements present in the 3 beta-HSDI gene regulatory sequences. Deletion analyses indicated that removal of intron 1 strongly impaired the transcriptional activity directed by the 3 beta-HSDI basal promoter. Consequently, we focused our attention to the characterization of the 128 base pair first intronic sequence from the 3 beta-HSDI gene. A single protected region, designated the 3 beta I-A element, was identified by DNase I footprinting. Gel mobility shift assays indicated that at least four nuclear proteins with distinct biochemical and binding properties possess the ability to bind the 3 beta I-A element to produce four DNA-protein complexes (R1 to R4). However, the one producing R1, a 37-kilodalton protein that has been found in both human choriocarcinoma JEG-3 and adrenal cortex adenocarcinoma SW13 cells, as well as in all tested tissue culture cells, clearly accounts for the major 3 beta I-A-binding species. Site-directed mutagenesis provided the evidence that the 3 beta I-A element acts positively on the 3 beta-HSD-I gene promoter-mediated transcriptional activity upon transient transfection of both JEG-3 and SW13 cells. No homology has been found between the 3 beta I-A element and target sequences for other known transcription factors. In addition, of the four proteins binding the 3 beta I-A element, that producing R2 was identified as the positive transcription factor Sp1, whereas the identity of the remaining factors is still unknown. This is consistent with the presence of an Sp1 motif overlapping the 3 beta I-A element in intron 1, therefore pointing toward an important function played by this particular region in 3 beta-HSDI basal, but not cell-specific, gene expression.
已在胎盘和皮肤中检测到编码人I型3β-羟基类固醇脱氢酶(3β-HSDI)的基因高水平表达,但在肾上腺中未检测到,不过肾上腺表达高水平的II型3β-HSD。在本研究中,我们探讨了I型3β-HSD细胞特异性表达的差异模式是否可由3β-HSDI基因调控序列中存在的顺式作用调控元件的差异利用来解释。缺失分析表明,去除内含子1会强烈损害3β-HSDI基础启动子指导的转录活性。因此,我们将注意力集中在3β-HSDI基因128个碱基对的首个内含子序列的特征分析上。通过DNase I足迹法鉴定出一个单一的受保护区域,命名为3βI-A元件。凝胶迁移率变动分析表明,至少四种具有不同生化和结合特性的核蛋白能够结合3βI-A元件,产生四种DNA-蛋白质复合物(R1至R4)。然而,产生R1的那种蛋白,一种在人绒毛膜癌JEG-3细胞和肾上腺皮质腺癌SW13细胞以及所有测试的组织培养细胞中均已发现的37千道尔顿蛋白,显然是主要的3βI-A结合物种。定点诱变提供了证据,表明在JEG-3细胞和SW13细胞瞬时转染后,3βI-A元件对3β-HSD-I基因启动子介导的转录活性起正向作用。在3βI-A元件与其他已知转录因子的靶序列之间未发现同源性。此外,在结合3βI-A元件的四种蛋白质中,产生R2的那种蛋白被鉴定为正向转录因子Sp1,而其余因子的身份仍然未知。这与内含子1中与3βI-A元件重叠的Sp1基序的存在一致,因此表明该特定区域在3β-HSDI基础而非细胞特异性基因表达中发挥重要作用。